Ramelteon is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN). It is used for insomnia, particularly delayed sleep onset. Ramelteon has not been shown to produce dependence and has shown no potential for abuse.
We use cookies primarily to enhance your user experience and to analyze our web traffic. For more information, see our Privacy Policy. You can manage your cookie preferences in your browser’s privacy settings.